研究業績
2022年
Original Article
Kawashima Y, Fukuhara T, Saito H, Furuya N, Watanabe K, Sugawara S, Iwasawa S, Tsunezuka Y, Yamaguchi O, Okada M, Yoshimori K, Nakachi I, Seike M, Azuma K, Kurimoto F, Tsubata Y, Fujita Y, Nagashima H, Asai G, Watanabe S, Miyazaki M, Hagiwara K, Nukiwa T, Morita S, Kobayashi K, Maemondo M.: Bevacizumab plus erlotinib versus erlotinib alone in Japanese patients with advanced, metastatic, EGFR-mutant non-small-cell lung cancer. Lancet Respir Med.
Tanimura K, Yamada T, Okada K, Nakai K, Horinaka M, Katayama Y, Morimoto K, Ogura Y, Takeda T, Shiotsu S, Ichikawa K, Watanabe S, Morimoto Y, Iwasaku M, Kaneko Y, Uchino J, Taniguchi H, Yoneda K, Matoba S, Sakai T, Uehara H, Yano S, Kusaba T, Katayama R, Takayama K.: HER3 activation contributes toward the emergence of ALK inhibitor-tolerant cells in ALK-rearranged lung cancer with mesenchymal features. NPJ Precis Oncol.
Yanagimura N, Takeuchi S, Fukuda K, Arai S, Tanimoto A, Nishiyama A, Ogo N, Takahashi H, Asai A, Watanabe S, Kikuchi T, Yano S.: STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosis. NPJ Precis Oncol.
Ichikawa K, Watanabe S, Miura S, Ohtsubo A, Shoji S, Nozaki K, Tanaka T, Saida Y, Kondo R, Hokari S, Aoki N, Ohshima Y, Koya T, Kikuchi T.: Prognostic significance of procalcitonin in small cell lung cancer. Transl Lung Cancer Res.
Oizumi S, Takamura K, Harada T, Tachihara M, Morikawa N, Honda R, Watanabe S, Asao T, Kunisaki M, Fukuhara T, Noro R, Kikuchi E, Tsutani Y, Tenma T, Kobayashi K, Dosaka-Akita H.: Phase II study of carboplatin-paclitaxel alone or with bevacizumab in advanced sarcomatoid carcinoma of the lung: HOT1201/NEJ024. Int J Clin Oncol.
Shima K, Arumugam P, Sallese A, Horia Y, Ma Y, Trapnell C, Wessendarp M, Chalk C, McCarthy C, Carey BC, Trapnell BC, Suzuki T.: A Murine Model of Hereditary Pulmonary Alveolar Proteinosis Caused by Homozygous Csf2ra Gene Disruption Am J Physiol Lung Cell Mol Physiol.
Koyama K, Miura S, Watanabe S, Shoji S, Koshio J, Hayashi Y, Ishikawa D, Sato K, Miyabayashi T, Okajima M, Ota T, Tanaka T, Matsumoto N, Kuriyama H, Abe T, Nozaki K, Ichikawa K, Kondo R, Tanaka H, Kikuchi T.: Observational study of rebiopsy in EGFR-TKI-resistant patients with EGFR mutation-positive advanced NSCLC. Sci Rep.
Okano H, Sakuraya M, Masuyama T, Kimata S, Hokari S.: Respiratory support strategy in adults with acute hypoxemic respiratory failure: a systematic review and network meta-analysis. JA Clin Rep.
Ishida T, Seki M, Oishi K, Tateda K, Fujita J, Kadota JI, Kawana A, Izumikawa K, Kikuchi T, Ohmagari N, Yamada M, Maruyama T, Takazono T, Miki M, Miyazaki Y, Yamazaki Y, Kakeya H, Ogawa K, Nagai H, Watanabe A.: Clinical manifestations of hospitalized influenza patients without risk factors: A prospective multicenter cohort study in Japan via internet surveillance. J Infect Chemother.
Takahashi M, Watanabe S, Suzuki R, Arita M, Sato K, Sato M, Sekiya Y, Abe Y, Fujisaki T, Ohtsubo A, Shoji S, Nozaki K, Ichikawa K, Kondo R, Saida Y, Hokari S, Aoki N, Hayashi M, Ohshima Y, Koya T, Kikuchi T.: PD-1 blockade therapy augments the antitumor effects of lymphodepletion and adoptive T cell transfer. Cancer Immunol Immunother.
Cao S, Zhang Y, Zhou Y, Rong W, Wang Y, Ling X, Zhang L, Li J, Tomita Y, Watanabe S, Nakada T, Seki N, Hida T, Dermime S, Zhong R, Zhong H.: A nomogram for predicting hyperprogressive disease after immune checkpoint inhibitor treatment in lung cancer. Transl Lung Cancer Res.
He BX, Zhong YF, Zhu YB, Deng JJ, Fang MJ, She YL, Wang TT, Yang Y, Sun XW, Belluomini L, Watanabe S, Dong D, Tian J, Xie D.: Deep learning for predicting immunotherapeutic efficacy in advanced non-small cell lung cancer patients: a retrospective study combining progression-free survival risk and overall survival risk. Transl Lung Cancer Res.
Tasaka S, Ohshimo S, Takeuchi M, Yasuda H, Ichikado K, Tsushima K, Egi M, Hashimoto S, Shime N, Saito O, Matsumoto S, Nango E, Okada Y, Hayashi K, Sakuraya M, Nakajima M, Okamori S, Miura S, Fukuda T, Ishihara T, Kamo T, Yatabe T, Norisue Y, Aoki Y, Iizuka Y, Kondo Y, Narita C, Kawakami D, Okano H, Takeshita J, Anan K, Okazaki SR, Taito S, Hayashi T, Mayumi T, Terayama T, Kubota Y, Abe Y, Iwasaki Y, Kishihara Y, Kataoka J, Nishimura T, Yonekura H, Ando K, Yoshida T, Masuyama T, Sanui M; ARDS Clinical Practice Guideline 2021 committee from the Japanese Society of Intensive Care Medicine, the Japanese Respiratory Society, and the Japanese Society of Respiratory Care Medicine.: ARDS Clinical Practice Guideline 2021. J Intensive Care.
Tasaka S, Ohshimo S, Takeuchi M, Yasuda H, Ichikado K, Tsushima K, Egi M, Hashimoto S, Shime N, Saito O, Matsumoto S, Nango E, Okada Y, Hayashi K, Sakuraya M, Nakajima M, Okamori S, Miura S, Fukuda T, Ishihara T, Kamo T, Yatabe T, Norisue Y, Aoki Y, Iizuka Y, Kondo Y, Narita C, Kawakami D, Okano H, Takeshita J, Anan K, Okazaki SR, Taito S, Hayashi T, Mayumi T, Terayama T, Kubota Y, Abe Y, Iwasaki Y, Kishihara Y, Kataoka J, Nishimura T, Yonekura H, Ando K, Yoshida T, Masuyama T, Sanui M; ARDS Clinical Practice Guideline Committee 2021 from the Japanese Respiratory Society, the Japanese Society of Intensive Care Medicine, and the Japanese Society of Respiratory Care Medicine.: ARDS clinical practice guideline 2021 Respir Investig.
Ohashi K, Ito R, Koda R, Iino N, Takada T.: Serum cytokine changes induced by direct hemoperfusion with polymyxin B-immobilized fiber in patients with acute respiratory failure Respir Investig.
Yamaguchi O, Kaira K, Naruse I, Umeda Y, Honda T, Watanabe S, Ichikawa K, Tateishi K, Kasahara N, Higuchi T, Hashimoto K, Shinomiya S, Miura Y, Shiono A, Mouri A, Imai H, Iizuka K, Ishizuka T, Minato K, Suda S, Kagamu H, Mori K, Kuji I, Seki N.: Prospective assessment using 18F-FDG PET/CT as a novel predictor for early response to PD-1 blockade in non-small-cell lung cancer. Sci Rep.
Ozawa M, Nakajima S, Kobayashi D, Tomii K, Li NJ, Watarai T, Suzuki R, Watanabe S, Kanda Y, Takeuchi A, Katakai T: Micro- and Macro-Anatomical Frameworks of Lymph Nodes Indispensable for the Lymphatic System Filtering Function Front Cell Dev Biol.
Hotta K, Hida T, Nokihara H, Morise M, Kim YH, Azuma K, Seto T, Takiguchi Y, Nishio M, Yoshioka H, Kumagai T, Watanabe S, Goto K, Satouchi M, Kozuki T, Shukuya T, Nakagawa K, Mitsudomi T, Yamamoto N, Asakawa T, Yoshimoto T, Takata S, Tamura T.: Final overall survival analysis from the phase III J-ALEX study of alectinib versus crizotinib in ALK inhibitor-naïve Japanese patients with ALK-positive non-small-cell lung cancer. ESMO open.
Seki T, Saida Y, Kishimoto S, Lee J, Otowa Y, Yamamoto K, Chandramouli GV, Devasahayam N, Mitchell JB, Krishna MC, Brender JR: PEGPH20, a PEGylated human hyaluronidase, induces radiosensitization by reoxygenation in pancreatic cancer xenografts. A molecular imaging study Neoplasia.
Miyashita N, Higa F, Aoki Y, Kikuchi T, Seki M, Tateda K, Maki N, Uchino K, Kiyota H, Watanabe A.: Usefulness of the Legionella Score for differentiating from COVID-19 pneumonia to legionella pneumonia. J Infect Chemother.
Abe T, Hakamata M, Nishiyama A, Tateishi Y, Matsumoto S, Hemmi H, Ueda D, Sato T.: Identification and functional analysis of a new type of Z,E-mixed prenyl reductase from mycobacteria FEBS J.
Nishiyama Y, Koya T, Nagano K, Abe S, Kimura Y, Shima K, Toyama-Kosaka M, Hasegawa T, Sasaki T, Shinbori K, Ueki S, Takamura K, Kikuchi T.: Two cases of dupilumab-associated eosinophilic pneumonia in asthma with eosinophilic chronic rhinosinusitis: IL-5-driven pathology? Allergol Int.
Shoji S, Miura S, Watanabe S, Ohtsubo A, Nozaki K, Saida Y, Ichikawa K, Kondo R, Tanaka T, Koyama K, Tanaka H, Okajima M, Abe T, Ota T, Ishida T, Makino M, Iwashima A, Sato K, Matsumoto N, Yoshizawa H, Kikuchi T.: Phase II study of nanoparticle albumin-bound paclitaxel monotherapy for relapsed non-small cell lung cancer with patient-reported outcomes (NLCTG1302). Transl Lung Cancer Res.
Kushiro K, Watanabe S, Goto Y, Fujisaki T, Yanagimura N, Ohtsubo A, Shoji S, Nozaki K, Tanaka T, Saida Y, Sato Y, Ota T, Koshio J, Hayashi Y, Miyabayashi T, Matsumoto N, Ichikawa K, Koyama K, Kikuchi T.: Efficacy and safety of amrubicin therapy after chemoimmunotherapy in small cell lung cancer patients. Transl Lung Cancer Res.
Ogata H, Aoki N, Nagano K, Hakamata M, Bamba Y, Shibata S, Koizumi T, Ohshima Y, Watanabe S, Moro H, Koya T, Kikuchi T.: Factors associated with cytomegalovirus antigenemia in patients with rheumatic disease: A retrospective study. J Infect Chemother.
Koya T, Sakai N, Sasaki T, Shinbori K, Nagai A, Kimura Y, Toyama M, Hayashi M, Saito A, Nishiyama Y, Hasegawa T, Muramatsu Y, Muramatsu K, Horii A, Kikuchi T.: Effect of Dupilumab on Depression in Asthma with Eosinophilic Chronic Rhinosinusitis in the Japanese Population. Int Arch Allergy Immunol.
Nagano K, Kawasaki S, Moro H, Chang B, Bamba Y, Yamamoto A, Morita M, Ohnishi M, Shibata S, Koizumi T, Aoki N, Honma Y, Abe T, Koya T, Aoki N, Kikuchi T.: An outbreak of serotype 19A pneumococcal pneumonia in a relief facility in Japan. Infect Control Hosp Epidemiol.
Asao T, Watanabe S, Tanaka T, Morita S, Kobayashi K.: A phase II study of carboplatin and etoposide plus durvalumab for previously untreated extensive-stage small-cell lung cancer (ES-SCLC) patients with a poor performance status (PS): NEJ045A study protocol. BMC Cancer.
Watanabe S, Sakai K, Matsumoto N, Koshio J, Ishida A, Abe T, Ishikawa D, Tanaka T, Aoki A, Kajiwara T, Koyama K, Miura S, Goto Y, Sekiya T, Suzuki R, Kushiro K, Fujisaki T, Yanagimura N, Ohtsubo A, Shoji S, Nozaki K, Saida Y, Yoshizawa H, Nishio K, Kikuchi T.: Phase II Trial of the Combination of Alectinib with Bevacizumab in Alectinib Refractory ALK-Positive Nonsquamous Non-Small-Cell Lung Cancer (NLCTG1501) Cancers (Basel).
Case Report
Nozaki K, Watanabe S, Nishio K, Sakai K, Kikuchi T: Effectiveness of afatinib in an NSCLC patient with EGFR mutation and early progression to osimertinib: a case report Transl Cancer Res.
Nishiyama Y, Koya T, Nagano K, Abe S, Kimura Y, Shima K, Toyama-Kosaka M, Hasegawa T, Sasaki T, Shinbori K, Ueki S, Takamura K, Kikuchi T.: Two cases of dupilumab-associated eosinophilic pneumonia in asthma with eosinophilic chronic rhinosinusitis: IL-5-driven pathology? Allergol Int.
Aoki A, Saito A, Shima K, Kimura Y, Asakawa K, Ohashi R, Umezu H, Sakagami T, Moriyama H, Kikuchi T.: Occupational Lung Disease Caused by Exposure to Polytetrafluoroethylene Intern Med.
Shoji S, Watanabe S, Hanazawa Y, Fujisaki T, Kikuchi T.: Three non-small cell lung cancer patients who developed pulmonary thromboses during osimertinib treatment and could safely resume concomitant anticoagulation treatment: a report of three cases Transl Lung Cancer Res.
Review
Letter/Correspondence
和文総説
村井裕衣、小屋俊之、菊地利明: 生物学的製剤:デュピルマブ 呼吸器内科
奈良本駿、小屋俊之、長谷川隆志、木村陽介、島賢治郎、青木亜美、林正周、酒井菜摘、田中健太郎、坪川史人、筒井裕一、新堀香織、佐々木崇暢、堀井新、村松芳幸、真島一郎、村松公美子、菊池利明: Dupilumab導入によるうつ症状への影響 心身医学
田中知宏、三浦理: がん腫に関係なくTMB-HighはPD-1/PD-L1阻害薬のバイオマーカーとなりうるか KEYNOTE-158試験の結果からの考察 がん分子標的治療
受賞・表彰
渡部聡: 新潟県医師会学術奨励賞 進行期固形腫瘍を標的とした多様性遺伝子改変T細胞療法の開発
森谷梨加: 第59回睡眠呼吸障害研究会優秀賞 閉塞性睡眠時無呼吸症候群患者における慢性間欠的低酸素血症が腎尿細管間質障害におよぼす影響の検討
渡辺裕介(指導:穂苅諭): 医学生・研修医の日本内科学会ことはじめ2022 京都 優秀演題賞 肺胞低換気と上腸間膜動脈症候群を呈し、ALPL遺伝子変異を認めたSilver-Russell症候群の成人例
早福はるか: 第62回日本呼吸器学会学術講演会 呼吸器病学ことはじめ アナライザーセッション優秀賞 慢性的なテフロン™曝露による異物肉芽腫性肺疾患の1例
才田優: 第26回有壬記念学術奨励賞 代謝イメージングを用いた免疫チェックポイント障害薬による早期治療反応の検出
才田優: 第9回学長賞(若手教員研究奨励) Multimodal Molecular Imaging Detects Early Responses to Immune Checkpoint Blockade
森谷梨加: 第31回PneumoForum 優秀賞 閉塞性睡眠時無呼吸症候群患者における慢性間欠的低酸素血症が腎尿細管間質障害におよぼす影響の検討
宮加谷昌紀(指導:穂苅諭): 第89回呼吸器合同北陸地方会研修医セッション優秀演題賞 骨髄異形成症候群を伴い両肺浸潤影による呼吸不全で致命的な経過をとった VEXAS症候群の一例
柳村尚寛: 日本肺癌学会若手奨励賞 STAT3 inhibition suppresses adaptive survival of ALK-rearranged lung cancer cells through transcriptional modulation of apoptosis
才田優: 新潟県医師会学術研究助成金 癌免疫における脂肪酸代謝の機序解明と代謝チェックポイント阻害による癌免疫療法の開発